Technetium-99m disofenin *DISCONTINUED 2019*

Approved Use: Hepatobiliary imaging agent indicated in the diagnosis of acute cholecystitis as well as to rule out the occurrence of acute cholecystitis in suspected patients with right upper quadrant pain, fever, jaundice, right upper quadrant tenderness and mass or rebound tenderness, but not limited to these signs and symptoms 
Dose:

• Non-jaundiced patient: 1 - 5 mCi
• Patients with serum bilirubin > 5 mg/dL: 3 - 8 mCi 

Brand Name: Hepatolite®
Manufacturer: Pharmalucence
Package Insert
How Supplied:

• 5 vial kit (NDC: 45567-0475-1)
• 30 vial kit (NDC: 45567-0475-2)

​Storage: Protect from light

Clinical Guidelines:

• ACR-SPR Practice Parameter for the Performance of Hepatobiliary Scintigraphy (2017)
• SNMMI Procedure Standard for Hepatobiliary Scintigraphy 4.0 (2010)